Senseonics (NYSE:SENS) Shares Gap Up - Here's Why

Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report)'s stock price gapped up before the market opened on Thursday . The stock had previously closed at $1.17, but opened at $1.23. Senseonics shares last traded at $1.29, with a volume of 5,848,861 shares changing hands.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on SENS shares. HC Wainwright reissued a "buy" rating and issued a $2.00 price objective on shares of Senseonics in a research note on Friday, November 15th. StockNews.com began coverage on shares of Senseonics in a report on Thursday, December 26th. They issued a "sell" rating for the company.

Senseonics Stock Performance

The business's 50-day moving average price is $0.78 and its 200-day moving average price is $0.50. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The stock has a market cap of $654.86 million, a PE ratio of -8.46 and a beta of 0.69.

Insiders Place Their Bets

In other Senseonics news, CEO Timothy T. Goodnow acquired 315,000 shares of the company's stock in a transaction dated Tuesday, December 10th. The shares were acquired at an average cost of $0.31 per share, with a total value of $97,650.00. Following the acquisition, the chief executive officer now directly owns 11,310,355 shares of the company's stock, valued at approximately $3,506,210.05. The trade was a 2.86 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Frederick T. Sullivan bought 124,933 shares of the firm's stock in a transaction that occurred on Thursday, December 12th. The stock was purchased at an average price of $0.38 per share, with a total value of $47,474.54. Following the completion of the purchase, the chief financial officer now owns 2,478,844 shares in the company, valued at approximately $941,960.72. This trade represents a 5.31 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Senseonics

Large investors have recently made changes to their positions in the company. Symmetry Partners LLC acquired a new position in Senseonics during the third quarter worth $164,000. GSA Capital Partners LLP purchased a new position in Senseonics during the third quarter worth about $117,000. FMR LLC boosted its stake in Senseonics by 48,267.2% during the third quarter. FMR LLC now owns 168,318 shares of the company's stock worth $59,000 after buying an additional 167,970 shares during the period. Geode Capital Management LLC boosted its stake in Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company's stock worth $2,042,000 after buying an additional 179,103 shares during the period. Finally, Ridgecrest Wealth Partners LLC acquired a new stake in shares of Senseonics during the fourth quarter worth about $60,000. 12.36% of the stock is currently owned by institutional investors and hedge funds.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.